APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Capecitabine Fumarate

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Capecitabine Fumarate Industry Growth and Trends Forecast to 2032

Report ID 173974650126 December 2025102 pages

Choose your research edition.

Industry ResearchCapecitabine Fumarate Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Capecitabine Fumarate Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Capecitabine Fumarate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Capecitabine Fumarate Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Capecitabine Fumarate Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Capecitabine Fumarate market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Capecitabine Fumarate is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Capecitabine Fumarate is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Capecitabine Fumarate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Capecitabine Fumarate include Akorn, Dr Reddys, Emcure Pharms, Gland Pharma, Hikma Farmaceutica, Sagent Pharms, Sun Pharma Global, Pfizer and Mylan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Capecitabine Fumarate market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Capecitabine Fumarate market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Capecitabine Fumarate market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Capecitabine Fumarate.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Capecitabine Fumarate market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Capecitabine Fumarate Market by Company

Akorn

Dr Reddys

Emcure Pharms

Gland Pharma

Hikma Farmaceutica

Sagent Pharms

Sun Pharma Global

Pfizer

Mylan

Novartis

Capecitabine Fumarate Segment by Type

Capecitabine Fumarate Oral

Capecitabine Fumarate Infusion

Capecitabine Fumarate Segment by Application

Colon Cancer

Breast Cancer

Gastric Cancer

Rectal Cancer

Other Malignancies

Capecitabine Fumarate Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Capecitabine Fumarate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Capecitabine Fumarate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Capecitabine Fumarate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Capecitabine Fumarate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Capecitabine Fumarate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Capecitabine Fumarate Oral Table 2. Major Company of Capecitabine Fumarate Infusion Table 3. Global Capecitabine Fumarate Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Capecitabine Fumarate Sales by Type (2021-2026) & (K Units) Table 5. Global Capecitabine Fumarate Sales Market Share in Volume by Type (2021-2026) Table 6. Global Capecitabine Fumarate Sales by Type (2021-2026) & (US$ Million) Table 7. Global Capecitabine Fumarate Sales Market Share in Value by Type (2021-2026) Table 8. Global Capecitabine Fumarate Price by Type (2021-2026) & (US$/Unit) Table 9. Global Capecitabine Fumarate Sales by Type (2027-2032) & (K Units) Table 10. Global Capecitabine Fumarate Sales Market Share in Volume by Type (2027-2032) Table 11. Global Capecitabine Fumarate Sales by Type (2027-2032) & (US$ Million) Table 12. Global Capecitabine Fumarate Sales Market Share in Value by Type (2027-2032) Table 13. Global Capecitabine Fumarate Price by Type (2027-2032) & (US$/Unit) Table 14. North America Capecitabine Fumarate Sales by Type (2021-2026) & (K Units) Table 15. North America Capecitabine Fumarate Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Capecitabine Fumarate Sales by Type (2021-2026) & (K Units) Table 17. Europe Capecitabine Fumarate Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Capecitabine Fumarate Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Capecitabine Fumarate Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Capecitabine Fumarate Sales by Type (2021-2026) & (K Units) Table 21. Latin America Capecitabine Fumarate Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Capecitabine Fumarate Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Capecitabine Fumarate Sales by Type (2021-2026) & (US$ Million) Table 24. Capecitabine Fumarate Industry Trends Table 25. Capecitabine Fumarate Industry Drivers Table 26. Capecitabine Fumarate Industry Opportunities and Challenges Table 27. Capecitabine Fumarate Industry Restraints Table 28. Global Capecitabine Fumarate Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Capecitabine Fumarate Revenue Market Share by Company (2021-2026) Table 30. Global Capecitabine Fumarate Sales by Company (2021-2026) & (K Units) Table 31. Global Capecitabine Fumarate Sales Share by Company (2021-2026) Table 32. Global Capecitabine Fumarate Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Capecitabine Fumarate Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Capecitabine Fumarate Major Company Production Sites and Headquarters Table 35. Global Capecitabine Fumarate Company, Product Type & Application Table 36. Global Capecitabine Fumarate Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Capecitabine Fumarate by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Capecitabine Fumarate Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Capecitabine Fumarate Sales by Region (2021-2026) & (K Units) Table 41. Global Capecitabine Fumarate Sales Market Share in Volume by Region (2021-2026) Table 42. Global Capecitabine Fumarate Sales by Region (2021-2026) & (US$ Million) Table 43. Global Capecitabine Fumarate Sales Market Share in Value by Region (2021-2026) Table 44. Global Capecitabine Fumarate Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Capecitabine Fumarate Sales by Region (2027-2032) & (K Units) Table 46. Global Capecitabine Fumarate Sales Market Share in Volume by Region (2027-2032) Table 47. Global Capecitabine Fumarate Sales by Region (2027-2032) & (US$ Million) Table 48. Global Capecitabine Fumarate Sales Market Share in Value by Region (2027-2032) Table 49. Global Capecitabine Fumarate Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Capecitabine Fumarate Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Capecitabine Fumarate Sales by Application (2021-2026) & (K Units) Table 52. Global Capecitabine Fumarate Sales Market Share in Volume by Application (2021-2026) Table 53. Global Capecitabine Fumarate Sales by Application (2021-2026) & (US$ Million) Table 54. Global Capecitabine Fumarate Sales Market Share in Value by Application (2021-2026) Table 55. Global Capecitabine Fumarate Price by Application (2021-2026) & (US$/Unit) Table 56. Global Capecitabine Fumarate Sales by Application (2027-2032) & (K Units) Table 57. Global Capecitabine Fumarate Sales Market Share in Volume by Application (2027-2032) Table 58. Global Capecitabine Fumarate Sales by Application (2027-2032) & (US$ Million) Table 59. Global Capecitabine Fumarate Sales Market Share in Value by Application (2027-2032) Table 60. Global Capecitabine Fumarate Price by Application (2027-2032) & (US$/Unit) Table 61. North America Capecitabine Fumarate Sales by Application (2021-2026) & (K Units) Table 62. North America Capecitabine Fumarate Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Capecitabine Fumarate Sales by Application (2021-2026) & (K Units) Table 64. Europe Capecitabine Fumarate Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Capecitabine Fumarate Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Capecitabine Fumarate Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Capecitabine Fumarate Sales by Application (2021-2026) & (K Units) Table 68. Latin America Capecitabine Fumarate Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Capecitabine Fumarate Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Capecitabine Fumarate Sales by Application (2021-2026) & (US$ Million) Table 71. Akorn Company Information Table 72. Akorn Business Overview Table 73. Akorn Capecitabine Fumarate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Akorn Capecitabine Fumarate Product Portfolio Table 75. Akorn Recent Development Table 76. Dr Reddys Company Information Table 77. Dr Reddys Business Overview Table 78. Dr Reddys Capecitabine Fumarate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Dr Reddys Capecitabine Fumarate Product Portfolio Table 80. Dr Reddys Recent Development Table 81. Emcure Pharms Company Information Table 82. Emcure Pharms Business Overview Table 83. Emcure Pharms Capecitabine Fumarate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Emcure Pharms Capecitabine Fumarate Product Portfolio Table 85. Emcure Pharms Recent Development Table 86. Gland Pharma Company Information Table 87. Gland Pharma Business Overview Table 88. Gland Pharma Capecitabine Fumarate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Gland Pharma Capecitabine Fumarate Product Portfolio Table 90. Gland Pharma Recent Development Table 91. Hikma Farmaceutica Company Information Table 92. Hikma Farmaceutica Business Overview Table 93. Hikma Farmaceutica Capecitabine Fumarate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Hikma Farmaceutica Capecitabine Fumarate Product Portfolio Table 95. Hikma Farmaceutica Recent Development Table 96. Sagent Pharms Company Information Table 97. Sagent Pharms Business Overview Table 98. Sagent Pharms Capecitabine Fumarate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Sagent Pharms Capecitabine Fumarate Product Portfolio Table 100. Sagent Pharms Recent Development Table 101. Sun Pharma Global Company Information Table 102. Sun Pharma Global Business Overview Table 103. Sun Pharma Global Capecitabine Fumarate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Sun Pharma Global Capecitabine Fumarate Product Portfolio Table 105. Sun Pharma Global Recent Development Table 106. Pfizer Company Information Table 107. Pfizer Business Overview Table 108. Pfizer Capecitabine Fumarate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Pfizer Capecitabine Fumarate Product Portfolio Table 110. Pfizer Recent Development Table 111. Mylan Company Information Table 112. Mylan Business Overview Table 113. Mylan Capecitabine Fumarate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Mylan Capecitabine Fumarate Product Portfolio Table 115. Mylan Recent Development Table 116. Novartis Company Information Table 117. Novartis Business Overview Table 118. Novartis Capecitabine Fumarate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Novartis Capecitabine Fumarate Product Portfolio Table 120. Novartis Recent Development Table 121. North America Capecitabine Fumarate Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. North America Capecitabine Fumarate Sales by Country (2021-2026) & (K Units) Table 123. North America Capecitabine Fumarate Sales Market Share by Country (2021-2026) Table 124. North America Capecitabine Fumarate Sales Forecast by Country (2027-2032) & (K Units) Table 125. North America Capecitabine Fumarate Sales Market Share Forecast by Country (2027-2032) Table 126. North America Capecitabine Fumarate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Capecitabine Fumarate Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Capecitabine Fumarate Market Share by Country (2021-2026) Table 129. North America Capecitabine Fumarate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Capecitabine Fumarate Market Share Forecast by Country (2027-2032) Table 131. Europe Capecitabine Fumarate Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Europe Capecitabine Fumarate Sales by Country (2021-2026) & (K Units) Table 133. Europe Capecitabine Fumarate Sales Market Share by Country (2021-2026) Table 134. Europe Capecitabine Fumarate Sales Forecast by Country (2027-2032) & (K Units) Table 135. Europe Capecitabine Fumarate Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Capecitabine Fumarate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Capecitabine Fumarate Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Capecitabine Fumarate Market Share by Country (2021-2026) Table 139. Europe Capecitabine Fumarate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Capecitabine Fumarate Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Capecitabine Fumarate Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Capecitabine Fumarate Sales by Country (2021-2026) & (K Units) Table 143. Asia-Pacific Capecitabine Fumarate Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Capecitabine Fumarate Sales Forecast by Country (2027-2032) & (K Units) Table 145. Asia-Pacific Capecitabine Fumarate Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Capecitabine Fumarate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Capecitabine Fumarate Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Capecitabine Fumarate Market Share by Country (2021-2026) Table 149. Asia-Pacific Capecitabine Fumarate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Capecitabine Fumarate Market Share Forecast by Country (2027-2032) Table 151. Latin America Capecitabine Fumarate Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Latin America Capecitabine Fumarate Sales by Country (2021-2026) & (K Units) Table 153. Latin America Capecitabine Fumarate Sales Market Share by Country (2021-2026) Table 154. Latin America Capecitabine Fumarate Sales Forecast by Country (2027-2032) & (K Units) Table 155. Latin America Capecitabine Fumarate Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Capecitabine Fumarate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Capecitabine Fumarate Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Capecitabine Fumarate Market Share by Country (2021-2026) Table 159. Latin America Capecitabine Fumarate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Capecitabine Fumarate Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Capecitabine Fumarate Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Capecitabine Fumarate Sales by Country (2021-2026) & (K Units) Table 163. Middle East and Africa Capecitabine Fumarate Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Capecitabine Fumarate Sales Forecast by Country (2027-2032) & (K Units) Table 165. Middle East and Africa Capecitabine Fumarate Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Capecitabine Fumarate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Capecitabine Fumarate Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Capecitabine Fumarate Market Share by Country (2021-2026) Table 169. Middle East and Africa Capecitabine Fumarate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Capecitabine Fumarate Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Capecitabine Fumarate Distributors List Table 174. Capecitabine Fumarate Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Capecitabine Fumarate Image Figure 2. Global Capecitabine Fumarate Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Capecitabine Fumarate Market Size (2021-2032) & (US$ Million) Figure 4. Global Capecitabine Fumarate Sales (2021-2032) & (K Units) Figure 5. Capecitabine Fumarate Oral Image Figure 6. Global Capecitabine Fumarate Oral Sales YoY Growth (2021-2032) & (K Units) Figure 7. Capecitabine Fumarate Infusion Image Figure 8. Global Capecitabine Fumarate Infusion Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Capecitabine Fumarate Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Capecitabine Fumarate Market Share by Type 2025 VS 2032 Figure 11. North America Capecitabine Fumarate Sales Market Share in Volume by Type in 2025 Figure 12. North America Capecitabine Fumarate Sales Market Share in Value by Type in 2025 Figure 13. Europe Capecitabine Fumarate Sales Market Share in Volume by Type in 2025 Figure 14. Europe Capecitabine Fumarate Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Capecitabine Fumarate Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Capecitabine Fumarate Sales Market Share in Value by Type in 2025 Figure 17. Latin America Capecitabine Fumarate Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Capecitabine Fumarate Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Capecitabine Fumarate Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Capecitabine Fumarate Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Capecitabine Fumarate Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Colon Cancer Image Figure 24. Global Colon Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 25. Breast Cancer Image Figure 26. Global Breast Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 27. Gastric Cancer Image Figure 28. Global Gastric Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 29. Rectal Cancer Image Figure 30. Global Rectal Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 31. Other Malignancies Image Figure 32. Global Other Malignancies Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Capecitabine Fumarate Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Capecitabine Fumarate Market Share by Application 2025 VS 2032 Figure 35. North America Capecitabine Fumarate Sales Market Share in Volume by Application in 2025 Figure 36. North America Capecitabine Fumarate Sales Market Share in Value by Application in 2025 Figure 37. Europe Capecitabine Fumarate Sales Market Share in Volume by Application in 2025 Figure 38. Europe Capecitabine Fumarate Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Capecitabine Fumarate Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Capecitabine Fumarate Sales Market Share in Value by Application in 2025 Figure 41. Latin America Capecitabine Fumarate Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Capecitabine Fumarate Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Capecitabine Fumarate Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Capecitabine Fumarate Sales Market Share in Value by Application in 2025 Figure 45. North America Capecitabine Fumarate Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Capecitabine Fumarate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Capecitabine Fumarate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Capecitabine Fumarate Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Capecitabine Fumarate Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Capecitabine Fumarate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Capecitabine Fumarate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Capecitabine Fumarate Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Capecitabine Fumarate Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Capecitabine Fumarate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Capecitabine Fumarate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Capecitabine Fumarate Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Capecitabine Fumarate Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Capecitabine Fumarate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Capecitabine Fumarate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Capecitabine Fumarate Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Capecitabine Fumarate Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Capecitabine Fumarate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Capecitabine Fumarate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Capecitabine Fumarate Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Capecitabine Fumarate Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Capecitabine Fumarate Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Capecitabine Fumarate Oral
  • Capecitabine Fumarate Infusion
Applications
  • Colon Cancer
  • Breast Cancer
  • Gastric Cancer
  • Rectal Cancer
  • Other Malignancies
Companies covered
  • Akorn
  • Dr Reddys
  • Emcure Pharms
  • Gland Pharma
  • Hikma Farmaceutica
  • Sagent Pharms
  • Sun Pharma Global
  • Pfizer
  • Mylan
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Capecitabine Fumarate Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Capecitabine Fumarate Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Capecitabine Fumarate Market by Type
  6. 1.3.1 Capecitabine Fumarate Oral
  7. 1.3.2 Capecitabine Fumarate Infusion
  8. 1.4 Global Capecitabine Fumarate Market Size by Type
  9. 1.4.1 Global Capecitabine Fumarate Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Capecitabine Fumarate Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Capecitabine Fumarate Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Capecitabine Fumarate Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Capecitabine Fumarate Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Capecitabine Fumarate Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Capecitabine Fumarate Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Capecitabine Fumarate Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Capecitabine Fumarate Industry Trends
  2. 2.2 Capecitabine Fumarate Industry Drivers
  3. 2.3 Capecitabine Fumarate Industry Opportunities and Challenges
  4. 2.4 Capecitabine Fumarate Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Capecitabine Fumarate Revenue (2021-2026)
  2. 3.2 Global Top Players by Capecitabine Fumarate Sales (2021-2026)
  3. 3.3 Global Top Players by Capecitabine Fumarate Price (2021-2026)
  4. 3.4 Global Capecitabine Fumarate Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Capecitabine Fumarate Major Company Production Sites & Headquarters
  6. 3.6 Global Capecitabine Fumarate Company, Product Type & Application
  7. 3.7 Global Capecitabine Fumarate Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Capecitabine Fumarate Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Capecitabine Fumarate Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Capecitabine Fumarate Tier 1, Tier 2, and Tier 3
4 Capecitabine Fumarate Regional Status and Outlook
  1. 4.1 Global Capecitabine Fumarate Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Capecitabine Fumarate Historic Market Size by Region
  3. 4.2.1 Global Capecitabine Fumarate Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Capecitabine Fumarate Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Capecitabine Fumarate Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Capecitabine Fumarate Forecasted Market Size by Region
  7. 4.3.1 Global Capecitabine Fumarate Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Capecitabine Fumarate Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Capecitabine Fumarate Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Capecitabine Fumarate by Application
  1. 5.1 Capecitabine Fumarate Market by Application
  2. 5.1.1 Colon Cancer
  3. 5.1.2 Breast Cancer
  4. 5.1.3 Gastric Cancer
  5. 5.1.4 Rectal Cancer
  6. 5.1.5 Other Malignancies
  7. 5.2 Global Capecitabine Fumarate Market Size by Application
  8. 5.2.1 Global Capecitabine Fumarate Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Capecitabine Fumarate Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Capecitabine Fumarate Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Capecitabine Fumarate Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Capecitabine Fumarate Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Capecitabine Fumarate Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Capecitabine Fumarate Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Capecitabine Fumarate Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Akorn
  2. 6.1.1 Akorn Company Information
  3. 6.1.2 Akorn Business Overview
  4. 6.1.3 Akorn Capecitabine Fumarate Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Akorn Capecitabine Fumarate Product Portfolio
  6. 6.1.5 Akorn Recent Developments
  7. 6.2 Dr Reddys
  8. 6.2.1 Dr Reddys Company Information
  9. 6.2.2 Dr Reddys Business Overview
  10. 6.2.3 Dr Reddys Capecitabine Fumarate Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Dr Reddys Capecitabine Fumarate Product Portfolio
  12. 6.2.5 Dr Reddys Recent Developments
  13. 6.3 Emcure Pharms
  14. 6.3.1 Emcure Pharms Company Information
  15. 6.3.2 Emcure Pharms Business Overview
  16. 6.3.3 Emcure Pharms Capecitabine Fumarate Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Emcure Pharms Capecitabine Fumarate Product Portfolio
  18. 6.3.5 Emcure Pharms Recent Developments
  19. 6.4 Gland Pharma
  20. 6.4.1 Gland Pharma Company Information
  21. 6.4.2 Gland Pharma Business Overview
  22. 6.4.3 Gland Pharma Capecitabine Fumarate Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Gland Pharma Capecitabine Fumarate Product Portfolio
  24. 6.4.5 Gland Pharma Recent Developments
  25. 6.5 Hikma Farmaceutica
  26. 6.5.1 Hikma Farmaceutica Company Information
  27. 6.5.2 Hikma Farmaceutica Business Overview
  28. 6.5.3 Hikma Farmaceutica Capecitabine Fumarate Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hikma Farmaceutica Capecitabine Fumarate Product Portfolio
  30. 6.5.5 Hikma Farmaceutica Recent Developments
  31. 6.6 Sagent Pharms
  32. 6.6.1 Sagent Pharms Company Information
  33. 6.6.2 Sagent Pharms Business Overview
  34. 6.6.3 Sagent Pharms Capecitabine Fumarate Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sagent Pharms Capecitabine Fumarate Product Portfolio
  36. 6.6.5 Sagent Pharms Recent Developments
  37. 6.7 Sun Pharma Global
  38. 6.7.1 Sun Pharma Global Company Information
  39. 6.7.2 Sun Pharma Global Business Overview
  40. 6.7.3 Sun Pharma Global Capecitabine Fumarate Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Sun Pharma Global Capecitabine Fumarate Product Portfolio
  42. 6.7.5 Sun Pharma Global Recent Developments
  43. 6.8 Pfizer
  44. 6.8.1 Pfizer Company Information
  45. 6.8.2 Pfizer Business Overview
  46. 6.8.3 Pfizer Capecitabine Fumarate Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Pfizer Capecitabine Fumarate Product Portfolio
  48. 6.8.5 Pfizer Recent Developments
  49. 6.9 Mylan
  50. 6.9.1 Mylan Company Information
  51. 6.9.2 Mylan Business Overview
  52. 6.9.3 Mylan Capecitabine Fumarate Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Mylan Capecitabine Fumarate Product Portfolio
  54. 6.9.5 Mylan Recent Developments
  55. 6.10 Novartis
  56. 6.10.1 Novartis Company Information
  57. 6.10.2 Novartis Business Overview
  58. 6.10.3 Novartis Capecitabine Fumarate Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Novartis Capecitabine Fumarate Product Portfolio
  60. 6.10.5 Novartis Recent Developments
7 North America by Country
  1. 7.1 North America Capecitabine Fumarate Sales by Country
  2. 7.1.1 North America Capecitabine Fumarate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Capecitabine Fumarate Sales by Country (2021-2026)
  4. 7.1.3 North America Capecitabine Fumarate Sales Forecast by Country (2027-2032)
  5. 7.2 North America Capecitabine Fumarate Market Size by Country
  6. 7.2.1 North America Capecitabine Fumarate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Capecitabine Fumarate Market Size by Country (2021-2026)
  8. 7.2.3 North America Capecitabine Fumarate Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Capecitabine Fumarate Sales by Country
  2. 8.1.1 Europe Capecitabine Fumarate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Capecitabine Fumarate Sales by Country (2021-2026)
  4. 8.1.3 Europe Capecitabine Fumarate Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Capecitabine Fumarate Market Size by Country
  6. 8.2.1 Europe Capecitabine Fumarate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Capecitabine Fumarate Market Size by Country (2021-2026)
  8. 8.2.3 Europe Capecitabine Fumarate Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Capecitabine Fumarate Sales by Country
  2. 9.1.1 Asia-Pacific Capecitabine Fumarate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Capecitabine Fumarate Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Capecitabine Fumarate Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Capecitabine Fumarate Market Size by Country
  6. 9.2.1 Asia-Pacific Capecitabine Fumarate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Capecitabine Fumarate Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Capecitabine Fumarate Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Capecitabine Fumarate Sales by Country
  2. 10.1.1 South America Capecitabine Fumarate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Capecitabine Fumarate Sales by Country (2021-2026)
  4. 10.1.3 South America Capecitabine Fumarate Sales Forecast by Country (2027-2032)
  5. 10.2 South America Capecitabine Fumarate Market Size by Country
  6. 10.2.1 South America Capecitabine Fumarate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Capecitabine Fumarate Market Size by Country (2021-2026)
  8. 10.2.3 South America Capecitabine Fumarate Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Capecitabine Fumarate Sales by Country
  2. 11.1.1 Middle East and Africa Capecitabine Fumarate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Capecitabine Fumarate Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Capecitabine Fumarate Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Capecitabine Fumarate Market Size by Country
  6. 11.2.1 Middle East and Africa Capecitabine Fumarate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Capecitabine Fumarate Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Capecitabine Fumarate Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Capecitabine Fumarate Value Chain Analysis
  2. 12.1.1 Capecitabine Fumarate Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Capecitabine Fumarate Production Mode & Process
  7. 12.2 Capecitabine Fumarate Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Capecitabine Fumarate Distributors
  10. 12.2.3 Capecitabine Fumarate Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst